Лечение невропатической боли с позиций доказательной медицины

1. Treede RD, Jensen TS, Campbell JN et al. Neuropathic pain: redefinition and a grading system for clinical research purposes. Neurology 2008; 70: 1630–5.
2. Gore M, Brandenburg NA, Hoffman DL et al. Burden of illness in painful diabetic peripheral neuropathy: the patients’ perspectives. Pain 2006; 7: 892–900.
3. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 2007; 68: 1178–82.
4. McDermott AM, Toelle TR, Rowbotham DJ et al. The burden of neuropathic pain: results of a cross-sectional survey. Eur J Pain 2006; 10: 127–35.
5. O’Connor AB. Neuropathic pain: a review of the quality of life impact, costs, and cost-effectiveness of therapy. Pharmacoeconomics 2009; 27: 95–112.
6. Oster G, Harding G, Dukes E et al. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. Pain 2005; 6: 356–63.
7. Алексеев В.В., Яхно Н.Н. Боль. Болезни нервной системы. Руководство для врачей. Под ред. Н.Н.Яхно и Д.Р.Штульмана. М.: Медицина, 2001. Т. 1; с. 106–24.
8. Решетняк В.К., Кукушкин М.Л. Боль: физиологические и патофизиологические аспекты. Актуальные вопросы патофизиологии (избранные лекции). Под ред. Б.Б.Мороза. М.: Медицина, 2001; с. 354–89.
9. Coderre TJ, Katz J, Vaccarino AL et al. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259–85.
10. Bonica JJ. Introduction: semantic, epidemiologic, and educational issues. Pain and central nervous system disease: The central pain syndromes. Casey K.L., editor. New York: Raven Press, 1991; p. 13–29.
11. Smith BH, Torrance N, Bennett MI, Lee AJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain 2007; 23: 143–9.
12. Torrance N, Smith BH, Watson MC, Bennett MI. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam Pract 2007; 24: 481–5.
13. Dworkin RH, O’Connor AB, Backonja M et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007; 132: 237–51.
14. Moulin DE, Clark AJ, Gilron I et al., for the Canadian Pain Society. Pharmacological management of chronic neuropathic pain – consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage 2007; 12: 13–21.
15. Attal N, Cruccu G, Haanpää M et al, for the EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153–69.
16. Oxford Centre for Evidence-based Medicine. Levels of evidence and grades of recommendation. http://www.cebm.net/index.aspx?o=1025
17. Cruccu G, Aziz TZ, Garcia-Larrea L et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007; 14: 952–70.
18. Колосова О.А., Осипова В.В. Современные аспекты клиники и патогенеза мигрени. Журн. невропатологии и психиатрии им. С.С.Корсакова. 1991; 5: 104–6.
19. Keefe FJ, Lefebvre J. Pain behavior concepts: Controversies, current status and future directions. In: G.Gebhart, D.L.Hammond, T.S.Jensen. Proceedings of the VII World Congress of Pain. New York: Elsevier, 1994; p. 127–48.
20. Sanders SH. Behavior assessment of clinical pain: appraisal of current status. New York: Academic Press. 1979; 8.
21. Wade JB, Price DD, Hamer R et al. An emotional component analysis of chronic pain. Pain 1990; 40: 303–10.
22. Haythornthwaite JA, Sieber WJ, Kerns RD. Depression and the chronic pain experience. Pain 1991; 46: 177–84.
23. Lynn R, Eysenck HJ. Tolerance for pain, extraversion and neuroticism. Percept Mot Skills 1961; 12: 161–2.
24. Рябус М.В. Лечение головной боли напряжения методом биологической обратной связи. Дис. канд. мед. наук. М., 1998.

М.В.Чурюканов1, Э.А.Катушкина2

1. ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России;
2. ФГБУ НИИ общей патологии и патофизиологии РАМН, Москва